| Product Code: ETC7648749 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Congenital Heart Disease Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Congenital Heart Disease Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Congenital Heart Disease Market - Industry Life Cycle |
3.4 Israel Congenital Heart Disease Market - Porter's Five Forces |
3.5 Israel Congenital Heart Disease Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Israel Congenital Heart Disease Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.7 Israel Congenital Heart Disease Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.8 Israel Congenital Heart Disease Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 Israel Congenital Heart Disease Market Revenues & Volume Share, By End Users, 2021 & 2031F |
3.10 Israel Congenital Heart Disease Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Israel Congenital Heart Disease Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of congenital heart diseases in Israel |
4.2.2 Technological advancements in diagnostic tools and treatment options |
4.2.3 Growing awareness about early detection and treatment of congenital heart diseases |
4.3 Market Restraints |
4.3.1 Limited access to specialized healthcare services in certain regions of Israel |
4.3.2 High cost associated with advanced treatments and surgeries |
4.3.3 Regulatory challenges in the approval process for new medical devices and procedures |
5 Israel Congenital Heart Disease Market Trends |
6 Israel Congenital Heart Disease Market, By Types |
6.1 Israel Congenital Heart Disease Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Congenital Heart Disease Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Israel Congenital Heart Disease Market Revenues & Volume, By Heart Valve Defects, 2021- 2031F |
6.1.4 Israel Congenital Heart Disease Market Revenues & Volume, By Heart Wall Defects, 2021- 2031F |
6.1.5 Israel Congenital Heart Disease Market Revenues & Volume, By Blood Vessel Defects, 2021- 2031F |
6.1.6 Israel Congenital Heart Disease Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Israel Congenital Heart Disease Market, By Diagnosis |
6.2.1 Overview and Analysis |
6.2.2 Israel Congenital Heart Disease Market Revenues & Volume, By Electrocardiogram, 2021- 2031F |
6.2.3 Israel Congenital Heart Disease Market Revenues & Volume, By Chest X-ray, 2021- 2031F |
6.2.4 Israel Congenital Heart Disease Market Revenues & Volume, By Echocardiogram, 2021- 2031F |
6.2.5 Israel Congenital Heart Disease Market Revenues & Volume, By Transoesophageal Echocardiogram, 2021- 2031F |
6.2.6 Israel Congenital Heart Disease Market Revenues & Volume, By Pulse Oximetry, 2021- 2031F |
6.2.7 Israel Congenital Heart Disease Market Revenues & Volume, By Exercise Stress Test, 2021- 2031F |
6.2.8 Israel Congenital Heart Disease Market Revenues & Volume, By Cardiac Catheterization, 2021- 2031F |
6.2.9 Israel Congenital Heart Disease Market Revenues & Volume, By Cardiac Catheterization, 2021- 2031F |
6.3 Israel Congenital Heart Disease Market, By Treatment |
6.3.1 Overview and Analysis |
6.3.2 Israel Congenital Heart Disease Market Revenues & Volume, By Medications, 2021- 2031F |
6.3.3 Israel Congenital Heart Disease Market Revenues & Volume, By Surgery, 2021- 2031F |
6.3.4 Israel Congenital Heart Disease Market Revenues & Volume, By Watchful Waiting, 2021- 2031F |
6.3.5 Israel Congenital Heart Disease Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Israel Congenital Heart Disease Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 Israel Congenital Heart Disease Market Revenues & Volume, By Oral, 2021- 2031F |
6.4.3 Israel Congenital Heart Disease Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.4.4 Israel Congenital Heart Disease Market Revenues & Volume, By Others, 2021- 2031F |
6.5 Israel Congenital Heart Disease Market, By End Users |
6.5.1 Overview and Analysis |
6.5.2 Israel Congenital Heart Disease Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.3 Israel Congenital Heart Disease Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.5.4 Israel Congenital Heart Disease Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Israel Congenital Heart Disease Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 Israel Congenital Heart Disease Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.6.3 Israel Congenital Heart Disease Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.6.4 Israel Congenital Heart Disease Market Revenues & Volume, By Others, 2021- 2031F |
7 Israel Congenital Heart Disease Market Import-Export Trade Statistics |
7.1 Israel Congenital Heart Disease Market Export to Major Countries |
7.2 Israel Congenital Heart Disease Market Imports from Major Countries |
8 Israel Congenital Heart Disease Market Key Performance Indicators |
8.1 Average age of diagnosis for congenital heart diseases in Israel |
8.2 Adoption rate of minimally invasive treatment techniques |
8.3 Number of accredited pediatric cardiologists in Israel |
8.4 Survival rate of infants undergoing corrective heart surgeries |
8.5 Rate of complications post-treatment for congenital heart diseases |
9 Israel Congenital Heart Disease Market - Opportunity Assessment |
9.1 Israel Congenital Heart Disease Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Israel Congenital Heart Disease Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
9.3 Israel Congenital Heart Disease Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.4 Israel Congenital Heart Disease Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 Israel Congenital Heart Disease Market Opportunity Assessment, By End Users, 2021 & 2031F |
9.6 Israel Congenital Heart Disease Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Israel Congenital Heart Disease Market - Competitive Landscape |
10.1 Israel Congenital Heart Disease Market Revenue Share, By Companies, 2024 |
10.2 Israel Congenital Heart Disease Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here